sameAs
Pemetrexed Plus Gemcitabine in Renal Cell CancerPazopanib or Pemetrexed and Crizotinib in Advanced CancerStudy of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial CancersBATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung CancerOn the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus InfectionA Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate ChemotherapyEfficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium FalciparumCisplatin, Pemetrexed, and Imatinib Mesylate in Malignant MesotheliomaImpact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate ResistanceAntifolate Effectiveness in ArthritisTPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
P4844
Q15304877-A6192755-6C08-4F63-BADF-2600583AC67EQ15633946-B2023126-BF43-4D44-A741-9BE569011DFAQ27085870-9A6511B6-B067-4353-B21D-185F283D6322Q27088402-11EF1966-A755-497A-AA74-93D020B57EF7Q27265261-5CA41411-0927-4621-835D-89ED179F7AAEQ27276340-BBCADFEC-22B7-4262-B2EC-8E584FEF03DAQ27281684-660ED766-EC83-4B85-A249-E5CE54936869Q27284716-B602875C-2E5A-4E1F-A987-1CF79E88BAC3Q27286805-9C210665-BB98-44BA-9AEF-52E3143F7545Q27293136-A3F7C4FC-A873-4341-A281-D21E509F369DQ415220-6EECF5FC-E339-47FD-A74B-DB120DB71A3AQ415734-06F0D70C-1E93-47CB-9FFF-855D8FB6A1A6Q421072-C2A0D075-C9A0-45CD-8C43-BB6A5628B0B8Q422226-2521BDA9-45EC-4C77-852A-A21A2D898F30Q422232-71A49431-2A79-4820-A578-749A7A177594Q422665-90D5782A-135E-457C-98AA-305E2ED85721Q4973047-C211FC56-DBEE-490A-B098-E2334F891252Q5198706-D7E15146-A0C1-4535-B1C5-0E69422A6279Q7048249-0D72349E-7E9A-455C-9F76-5AC52AA8C8FBQ7073016-DF4ADB75-67B2-440D-84D4-8BDFB0A19F38Q7842225-DBF3F5F2-86FA-40A6-A0CD-468FB9368298Q907480-A74055E0-E69D-44DD-89F0-4D61C9A760E4
P2868
Q61917999-F1E98878-5EE7-4CCC-ADBA-CF2AC1815D18Q63316465-019755EC-E23D-4413-BB8C-256FFD2FA4A4Q63573126-B0CC403C-7A67-459D-8E60-6B668E74328CQ64120969-24432AAD-7636-4DBF-83C5-1B1BA1EA8D42Q65346977-0CEABDD6-6FDA-4148-9C84-3ACF82977EBDQ65370531-AAF6F57D-D9B9-401A-B130-E516EDE8CAB9Q65371015-274AC866-26D2-4CB0-AC82-EE37BC70B5E5Q65385637-C6CF2092-A468-4878-B16F-A06C05FE7739Q66029045-E0F00EC4-A267-4258-834E-85EDE60469DEQ66061577-53A7F8B1-C749-44C8-BDAB-33B2DB909118Q66404029-A950D949-1E86-494A-9FE8-AB6A3CC834DD
P4844
description
Inhibitors of the enzyme, dihy ...... aluations annual, 1994, p2033)
@en
name
Antifolat
@sh
Antifolat
@sr
Antifolato
@es
Antifolato
@eu
Folic Acid Antagonists
@en
Thuốc kháng folate
@vi
مضاد الفولات
@ar
type
label
Antifolat
@sh
Antifolat
@sr
Antifolato
@es
Antifolato
@eu
Folic Acid Antagonists
@en
Thuốc kháng folate
@vi
مضاد الفولات
@ar
altLabel
Antifolate
@ar
Antifolate
@en
Antifolates
@en
Dihydrofolate Reductase Inhibitors
@en
المضادات الفولاتية
@ar
مضاد فولات
@ar
مضادات الفولات
@ar
prefLabel
Antifolat
@sh
Antifolat
@sr
Antifolato
@es
Antifolato
@eu
Folic Acid Antagonists
@en
Thuốc kháng folate
@vi
مضاد الفولات
@ar
P244
P486
P6366
P683
P244
sh85049647
P279
P486
P6366
2781382166
P672
D27.505.519.389.350